BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38330674)

  • 1. Current and emerging sequencing-based tools for precision cancer medicine.
    Edsjö A; Gisselsson D; Staaf J; Holmquist L; Fioretos T; Cavelier L; Rosenquist R
    Mol Aspects Med; 2024 Apr; 96():101250. PubMed ID: 38330674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the Future of Oncology and Precision Medicine through Data Science.
    Zaravinos A
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics.
    Pant S; Weiner R; Marton MJ
    Front Oncol; 2014; 4():78. PubMed ID: 24860780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies.
    Cao J; Chen L; Li H; Chen H; Yao J; Mu S; Liu W; Zhang P; Cheng Y; Liu B; Hu Z; Chen D; Kang H; Hu J; Wang A; Wang W; Yao M; Chrin G; Wang X; Zhao W; Li L; Xu L; Guo W; Jia J; Chen J; Wang K; Li G; Shi W
    Oncologist; 2019 Dec; 24(12):e1294-e1302. PubMed ID: 31409745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular pathological analysis through the ages].
    Walker M; Mayr EM; Koppermann ML; Terron A; Wagner Y; Kling C; Pfarr N
    Pathologie (Heidelb); 2024 May; 45(3):173-179. PubMed ID: 38619582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
    Miller FA; Hayeems RZ; Bytautas JP; Bedard PL; Ernst S; Hirte H; Hotte S; Oza A; Razak A; Welch S; Winquist E; Dancey J; Siu LL
    Eur J Hum Genet; 2014 Mar; 22(3):391-5. PubMed ID: 23860039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the Variants: Mutational Patterns in Next-Generation Sequencing Data for Cancer Precision Medicine.
    Parilla M; Ritterhouse LL
    Front Cell Dev Biol; 2020; 8():370. PubMed ID: 32509788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
    Damodaran S; Berger MF; Roychowdhury S
    Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
    Beigh MM
    Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision diagnostics in chronic lymphocytic leukemia: Past, present and future.
    Mollstedt J; Mansouri L; Rosenquist R
    Front Oncol; 2023; 13():1146486. PubMed ID: 37035166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.
    Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T
    BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics: From NGS Data to Biological Complexity in Variant Detection and Oncological Clinical Practice.
    Dotolo S; Esposito Abate R; Roma C; Guido D; Preziosi A; Tropea B; Palluzzi F; Giacò L; Normanno N
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
    Maggi E; Montagna C
    Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls.
    Horak P; Fröhling S; Glimm H
    ESMO Open; 2016; 1(5):e000094. PubMed ID: 27933214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer.
    Galland L; Roussot N; Desmoulins I; Mayeur D; Kaderbhai C; Ilie S; Hennequin A; Reda M; Albuisson J; Arnould L; Boidot R; Truntzer C; Ghiringhelli F; Ladoire S
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications.
    Moretto R; Elliott A; Zhang J; Arai H; Germani MM; Conca V; Xiu J; Stafford P; Oberley M; Abraham J; Spetzler D; Rossini D; Antoniotti C; Marshall J; Shields A; Lopes G; Lonardi S; Pietrantonio F; Tomasello G; Passardi A; Tamburini E; Santini D; Aprile G; Masi G; Falcone A; Lenz HJ; Korn M; Cremolini C
    J Natl Cancer Inst; 2022 Feb; 114(2):271-279. PubMed ID: 34469533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HRD-MILN: Accurately estimate tumor homologous recombination deficiency status from targeted panel sequencing data.
    Wang X; Xu Y; Zhang Y; Wang S; Zhang X; Yi X; Zhang S; Wang J
    Front Genet; 2022; 13():990244. PubMed ID: 36246633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.